| JIUZHOU-PHARMACY |
JIUZHOU-PHARMACY |
92%
|
Sales to Jiuzhou Pharmacy currently account for over 60% of the Company’s revenue and are expected to remain a significant source of revenue in the near term. |
| HANGZHOU-XIAORAN-PHARMACEUTICAL-CO-LTD |
HANGZHOU-XIAORAN-PHARMACEUTICAL-CO-LTD |
85%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| ZHENGCHEN-PHARMACEUTICAL-CO-LTD |
ZHENGCHEN-PHARMACEUTICAL-CO-LTD |
85%
|
e to make deliveries as necessary. Competition The wholesale pharmaceutical distribution industry in China is competitive and highly fragmented. We compete with regional distributors, such as Zhengch… |
| AN-JIUZHOU-PHARMACY-CO-LTD |
AN-JIUZHOU-PHARMACY-CO-LTD |
62%
|
icensed doctors of both western medicine and TCM on site for consultation, examination and treatment of common ailments at scheduled hours. During the year ended March 31, 2021, the Company sold its … |
| EQUINITI-TRUST-COMPANY |
EQUINITI-TRUST-COMPANY |
62%
|
ort. Our transfer agent is Equiniti Trust Company, , LLC, whose address is 48 Wall Street, Floor 23 New York, NY 10005, and whose telephone number is (800) 468-9716. The SEC maintains an internet sit… |
| HANGZHOU-JIUZHOU-GRAND-PHARMACY-CHAIN-CO-LTD |
HANGZHOU-JIUZHOU-GRAND-PHARMACY-CHAIN-CO-LTD |
62%
|
erate our pharmacies (including the medical clinics) through the following companies in China that we manage through contractual arrangements (refer to “ Contractual Arrangements with HJ Group and th… |
| HANGZHOU-QIANHONG-AGRICULTURE-DEVELOPMENT-CO-LTD |
HANGZHOU-QIANHONG-AGRICULTURE-DEVELOPMENT-CO-LTD |
62%
|
rol contractually, operates our “Jiuzhou Grand Pharmacy” stores; ● Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership) (“Jiuzhou Clinic”), which we control co… |
| HEALTH-MANAGEMENT-CO-LTD |
HEALTH-MANAGEMENT-CO-LTD |
62%
|
C are covered by insurance up to RMB 500,000 (USD 79,600 ) per bank. As of March 31, 2024 and 2023, the Company had deposits totaling $ 32,247,552 and $ 31,558,338 that were covered by such limited i… |
| HUADONG-PHARMACEUTICAL-CO-LTD |
HUADONG-PHARMACEUTICAL-CO-LTD |
62%
|
d by reference from our 2023 Annual Report under the caption “Logistics.” Suppliers We currently source retail products from approximately 26 suppliers, including trading companies and direct manufac… |
| PUBLIC-HEALTH-SERVICE-CO-LTD |
PUBLIC-HEALTH-SERVICE-CO-LTD |
62%
|
rol contractually, operates our “Jiuzhou Grand Pharmacy” stores; ● Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership) (“Jiuzhou Clinic”), which we control co… |
| WORKING-GROUP |
WORKING-GROUP |
62%
|
siness, financial condition and results of operations may be adversely affected if these events occur. For example, epidemics threaten people’s lives and may adversely affect their livelihood as well… |
| ZHEJIANG-JIUXIN-MEDICINE-CO-LTD |
ZHEJIANG-JIUXIN-MEDICINE-CO-LTD |
62%
|
. HISTORY AND DEVELOPMENT OF THE COMPANY. Overview We are a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People’s Republic of China (“PRC” or “China”). Pr… |
